Responding to developments | Cutting through the noise | Promoting diverse voices | Shaping opinion | Making connections | Pointing to the evidence

UK Antimicrobial Drug Registry to open October 2021

7th April 2021

BSAC is establishing a UK Drug Registry (UKAR) to provide prescribers and organisations the opportunity to capture real world usage of antimicrobial agents and identify where real clinical unmet needs lie. This will provide an invaluable resource for future research studies and also enable the sharing of best practice.

BSAC pays tribute to ‘antimicrobial resistance agenda champion’ Sir Paul Cosford

7th April 2021

The Officers, Chief Executive, and staff of BSAC are deeply saddened to hear that Sir Paul Cosford, PHE Emeritus Medical Director has died. Sir Paul’s contribution to public health was admirable, considerable and will be greatly missed.

BSAC and JAC team rise to the challenge to support Stop Superbugs

1st April 2021

This April, the team from BSAC and JAC are joining a group of fundraisers, including Una Health, Page Medical, as well as a number of other individual fundraisers, to help support our global health initiative, Stop Superbugs.

From Treatment Options to Precision Medicine: The Future of “Omics-Based” Antibiotic Resistance Surveillance Data

1st April 2021

To celebrate our 50th anniversary, we’re inviting a select number of experts to share what they see as being the 21st-century solutions to one of the biggest and most complex challenges of our generation: antimicrobial resistance. In this post, Professor Sabiha Essack, explores the future of infection prevention and control...

BSAC welcomes call for global treaty on pandemics – but it must major on AMR

31st March 2021

The British Society for Antimicrobial Chemotherapy (BSAC) welcomes the news that UK Prime Minister Boris Johnson has joined more than 20 international leaders in calling for a settlement that will help the world prepare for future pandemics, and is keen to ensure that, as a ‘slow-motion catastrophe’, antimicrobial resistance (AMR) is now made a top priority on the global health security agenda.

Hearts and minds: Why public engagement is vital in the battle to beat superbugs

25th March 2021

In some ways, antimicrobial resistance (AMR) is a lot like the problem of climate change. Both are complex existential threats that demand an equally complex response: new legislation, better market incentives, innovative new technologies, not to mention a sea-change in our relationship with animals, and towards consumption in general. They also require that people, at an individual level, to ‘do their bit’ and change their behaviours...

Global Antimicrobial Stewardship Accreditation Scheme

23rd March 2021

Helping healthcare facilities globally to measure and enhance IPC, data collection / usage and antimicrobial stewardship programmes. Reducing preventable deaths from infections through effective antimicrobial use

Call for Funding Partners: COVID-19 Research

15th March 2021

BSAC is seeking organisations interested in contributing funds to its grants programme.

1 2 3 6
GP? Pharmacist? Researcher? Social Scientist? Whatever field you work in, if you’re committed to fighting infection then we want you to join us as a BSAC Member.
Become a member
I have read and agree to the Privacy Policy

Having trouble finding what you're after?

Top